Horsford, Cohen Request IRS Guidance on Cannabis Tax Treatment
Two House Democrats asked Treasury for clarity on Section 280E application to state-legal cannabis operators.

Close-up of hand writing on tax form with calculator nearby on white surface.
Congressional Request Targets Longstanding Tax Ambiguity
The lawmakers asked Treasury to clarify whether businesses operating under state cannabis laws remain subject to the federal tax disallowance that bars standard business deductions. Section 280E prohibits entities trafficking in Schedule I or Schedule II controlled substances from deducting ordinary business expenses such as payroll, rent, and marketing costs. Cannabis remains a Schedule I drug under the Controlled Substances Act despite legalization in 38 states for medical use and 24 states for adult use.
Horsford chairs the Congressional Cannabis Caucus. Cohen sits on the House Judiciary Committee, which has jurisdiction over controlled-substance scheduling.
Effective Tax Rates Exceed 70 Percent for Many Operators
Cannabis retailers and cultivators routinely face effective federal tax rates above 70 percent because they can't deduct cost of goods sold beyond direct production expenses. A 2024 analysis by the National Cannabis Industry Association found that the average MSO pays an effective tax rate of 74 percent. Conventional C-corporations pay 21 percent. The disallowance applies to ancillary expenses including employee benefits, facility maintenance, and compliance costs.
Industry groups estimate that 280E compliance costs U.S. cannabis operators $1.8 billion annually in excess federal tax liability.
Letter Follows Rescheduling Speculation
The May 28 request arrives amid ongoing DEA review of a Health and Human Services recommendation to move cannabis to Schedule III. If the Drug Enforcement Administration reclassifies cannabis to Schedule III, Section 280E would no longer apply because the statute explicitly targets Schedule I and Schedule II substances. The DEA published a notice of proposed rulemaking in August 2024 but hasn't issued a final rule.
Treasury hasn't issued formal guidance on 280E application to state-licensed cannabis businesses since the Cole Memo era ended in 2018.
Horsford Represents Nevada's Fourth District
Horsford's district includes parts of North Las Vegas and covers a state where adult-use cannabis sales exceeded $1.2 billion in 2025. Nevada legalized recreational cannabis in 2017. It currently licenses 75 retail dispensaries and 31 cultivation facilities. The state collected $105 million in cannabis excise taxes in fiscal year 2025, according to the Nevada Department of Taxation.
Cohen represents Tennessee's Ninth District, which includes Memphis. Tennessee hasn't legalized adult-use or medical cannabis.
Request Does Not Propose Legislative Fix
The letter asked for administrative guidance rather than statutory reform, signaling that the lawmakers view Treasury as having interpretive authority under existing law. Previous bills to amend or repeal 280E, including the Small Business Tax Equity Act introduced in six consecutive Congresses, haven't advanced past committee. The current version, H.R. 1210, has 23 cosponsors.
Neither Horsford nor Cohen sits on the House Ways and Means Committee, which has jurisdiction over tax policy.
Industry Awaits Treasury Response Timeline
Treasury has no statutory deadline to respond to congressional requests for guidance. The department hasn't issued a public acknowledgment of the letter as of May 28. The IRS typically responds to formal congressional inquiries within 60 to 90 days, though complex tax-policy questions can take longer. The agency's Office of Chief Counsel handles interpretive guidance on controlled-substance taxation.
For full background on this issue, see the CannIntel topic hub on 280E tax reform.
What Comes Next
The political variable is whether Treasury will issue guidance before the DEA finalizes its rescheduling decision. If rescheduling occurs first, the guidance request becomes moot. Industry observers are watching for any signal that Treasury will clarify 280E application to ancillary services such as testing labs, security contractors, and software vendors that serve cannabis operators but don't touch the plant.
For complete background, history, and our ongoing coverage of this story:
Open the CannIntel topic hub →Frequently asked questions
What is Section 280E?
Section 280E of the Internal Revenue Code prohibits businesses trafficking in Schedule I or Schedule II controlled substances from deducting ordinary business expenses such as payroll, rent, and marketing. Cannabis remains Schedule I, so state-legal operators can't claim most federal deductions, resulting in effective tax rates often exceeding 70 percent.
Who are Representatives Horsford and Cohen?
Steven Horsford is a Democratic congressman representing Nevada's Fourth District and chairs the Congressional Cannabis Caucus. Steve Cohen is a Democratic congressman from Tennessee's Ninth District and serves on the House Judiciary Committee. Both sent the May 28 letter requesting IRS guidance on cannabis tax treatment.
Would rescheduling cannabis eliminate 280E liability?
Yes. If the DEA moves cannabis from Schedule I to Schedule III, Section 280E would no longer apply because the statute explicitly targets only Schedule I and Schedule II substances. Cannabis businesses could then deduct ordinary expenses like any other industry, reducing effective tax rates to standard corporate levels.
How much do cannabis operators pay in excess taxes under 280E?
Industry groups estimate that Section 280E costs U.S. cannabis operators approximately $1.8 billion annually in excess federal tax liability. A 2024 National Cannabis Industry Association analysis found the average MSO pays an effective federal tax rate of 74 percent compared to 21 percent for conventional C-corporations.
Has Congress tried to repeal Section 280E?
Yes. The Small Business Tax Equity Act, which would exempt state-legal cannabis businesses from 280E, has been introduced in six consecutive Congresses but has never advanced past committee. The current version, H.R. 1210, has 23 cosponsors. Horsford and Cohen's letter seeks administrative guidance rather than legislative reform.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws

Hawaii Denied 47 Gun Permits to Medical Marijuana Patients in 2025
Medical cannabis registration was the top reason Hawaii rejected firearm applications last year, state attorney general data shows.

Seven House Democrats Demand IRS Issue 280E Cannabis Tax Guidance
Congressional letter pressures Treasury to clarify deduction rules amid ongoing Schedule III reclassification.

Federal Medical Marijuana Recognition Raises Implementation Questions
Agencies face regulatory gaps after historic policy shift acknowledges medical value.
More from the newsroom

Stale Flower Cuts Dispensary Margins as Aging Inventory Forces Discounts
Slow-moving cannabis flower forces retailers into margin-killing markdowns, turning freshness into a financial control point.

Opioid Overdoses Decline After Marijuana Legalization, NORML Analysis Finds
New data analysis links legal cannabis markets to measurable reductions in fatal opioid poisonings.

Minnesota Home Grow Rights Face Federal Threat Under DEA Rescheduling Rule
DEA's proposed Schedule III rule could override state law allowing home cultivation for medical patients.